best scenario would be something like a placement to a sophisticated investor at about 0.07 cents? Building a view that the stock is currently undervalued given recent developments?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago